List of Levitra drug patents
Levitra is owned by Bayer Hlthcare.
Levitra contains Vardenafil Hydrochloride.
Levitra has a total of 2 drug patents out of which 0 drug patents have expired.
Levitra was authorised for market use on 19 August, 2003.
Levitra is available in tablet;oral dosage forms.
Levitra can be used as treatement of erectiile dysfunction by administering a film-coated tablet.
The generics of Levitra are possible to be released after 23 July, 2027.
| Patent Number | Company | Patent Title | Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US8841446 | BAYER HLTHCARE | Medicaments containing vardenafil hydrochloride trihydrate |
Jul, 2023
(5 months from now) | |
| US8273876 | BAYER HLTHCARE | Medicaments containing vardenafil hydrochloride trihydrate |
Jul, 2027
(4 years from now) | |
Drugs and Companies using VARDENAFIL HYDROCHLORIDE ingredient
Market Authorisation Date: 19 August, 2003
Treatment: Treatement of erectiile dysfunction by administering a film-coated tablet
Dosage: TABLET;ORAL
availability in other generic markets.
Click on the highlighted region to filter.
900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight
Join them to stay ahead in capturing the next drug going generic